Examining avian influenza virus exposure in seabirds of the northwest Atlantic in 2022 and 2023 via antibodies in eggs.

Abstract

Seabirds are frequently infected by avian influenza virus (AIV), which prior to 2021 primarily consisted of low-pathogenic AIV with limited reports of disease during infection. However, since highly pathogenic AIV (HPAIV) H5N1 clade 2.3.4.4b was introduced to North America in late 2021, HPAIV outbreaks in seabirds have occurred in multiple regions, with high levels of morbidity and mortality in many species. While monitoring active viral infections is critical for tracking disease burden, monitoring prior viral exposure via antibody detection in species that experienced large outbreaks is important for identifying individual- and population-level impacts of AIV on immunity and survival. We capitalized on ongoing egg collection programmes to assess the prevalence of antibodies against AIV nucleoprotein (NP) and hemagglutinin subtype 5 (H5) in 523 eggs collected in 2022 and 2023 from 11 seabird species that breed in the northwestern Atlantic, including primarily samples from eastern Canada and two from western Iceland. The prevalence of AIV antibodies in eggs varied across regions, species and years. American common eider (Somateria mollissima dresseri) eggs had the highest AIV antibody prevalence compared to sympatric species in 2023. Longitudinal samples were available for northern gannets (Morus bassanus) and American herring gulls (Larus argentatus smithsoniansus) at several sites, where the prevalence of anti-NP and anti-H5 antibodies increased from 2022 to 2023. Examining AIV antibody prevalence in seabird eggs can be a useful tool to investigate population-level AIV exposure, while we acknowledge our limited understanding of differential antibody waning rates and the relationship between titre and susceptibility.